A Comprehensive Review of Mechanical Circulatory Support Devices

Area of Science:

• Cardiology
• Medical Devices
• Critical Care Medicine

Background:

• Cardiogenic shock (CS) following acute myocardial infarction (AMI) has a high mortality rate, with limited advancements in treatment strategies over the past decade.
• Mechanical circulatory support (MCS) devices represent a novel therapeutic approach for CS, aiming to restore systemic perfusion and facilitate cardiac recovery or provide long-term support in heart failure.

Purpose of the Study:

• To provide an overview of currently available mechanical circulatory support (MCS) devices for cardiogenic shock (CS).
• To discuss the indications for the use of different MCS devices in the management of CS.
• To highlight the need for further research comparing MCS devices for CS patients.

Main Methods:

• Review of current literature on mechanical circulatory support (MCS) devices for cardiogenic shock (CS).
• Analysis of the role of hemodynamic parameters from right heart catheterization in guiding MCS selection and escalation.
• Discussion of commonly used short-term (intra-aortic balloon pump) and durable (Heartmate® 3) MCS devices, as well as emerging devices (Impella CP®).

Main Results:

• Mechanical circulatory support (MCS) devices are evolving as crucial treatment options for cardiogenic shock (CS).
• Current evidence comparing the efficacy of different MCS devices is limited, necessitating further investigation.
• The intra-aortic balloon pump offers modest support, while devices like Impella CP® and Heartmate® 3 are gaining prominence.

Conclusions:

• Mechanical circulatory support (MCS) devices are vital in managing cardiogenic shock (CS), offering diverse options for short-term and long-term support.
• Selection and escalation of MCS therapy are guided by hemodynamic parameters.
• There is a critical need for robust, randomized controlled trials to compare the effectiveness of various MCS devices in CS patients.